{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:15:33Z","timestamp":1791000933426,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1486-7","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T05:39:50Z","timestamp":1527658790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Role of p53\/miR-155-5p\/sirt1 loop in renal tubular injury of diabetic kidney disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Yue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-ji","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-jie","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1356-4780","authenticated-orcid":false,"given":"Yao-ming","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"issue":"9933","key":"1486_CR1","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0140-6736(14)60886-2","volume":"383","author":"Y Shi","year":"2014","unstructured":"Shi Y, Hu FB. The global implications of diabetes and cancer. Lancet. 2014;383(9933):1947\u20138.","journal-title":"Lancet"},{"issue":"4","key":"1486_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbrc.2013.02.120","volume":"433","author":"YM Sun","year":"2013","unstructured":"Sun YM, et al. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem Biophys Res Commun. 2013;433(4):359\u201361.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1486_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3181\/0705-MR-134","volume":"233","author":"YS Kanwar","year":"2008","unstructured":"Kanwar YS, et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood). 2008;233(1):4\u201311.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"Suppl 4","key":"1486_CR4","first-page":"8","volume":"26","author":"VM Dalla","year":"2000","unstructured":"Dalla VM, et al. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab. 2000;26(Suppl 4):8\u201314.","journal-title":"Diabetes Metab"},{"issue":"7","key":"1486_CR5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2215\/CJN.00520109","volume":"4","author":"M Kato","year":"2009","unstructured":"Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol. 2009;4(7):1255\u201366.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"1486_CR6","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1681\/ASN.2016121280","volume":"28","author":"MA Baker","year":"2017","unstructured":"Baker MA, et al. Tissue-specific MicroRNA expression patterns in four types of kidney disease. J Am Soc Nephrol. 2017;28(10):2985\u201392.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1486_CR7","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.3892\/mmr.2015.3327","volume":"11","author":"S Xie","year":"2015","unstructured":"Xie S, et al. Hypoxia-induced microRNA-155 promotes fibrosis in proximal tubule cells. Mol Med Rep. 2015;11(6):4555\u201360.","journal-title":"Mol Med Rep"},{"issue":"24","key":"1486_CR8","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1038\/onc.2012.305","volume":"32","author":"PM Neilsen","year":"2013","unstructured":"Neilsen PM, et al. Mutant p53 drives invasion in breast tumors through up-regulation of miR-155. Oncogene. 2013;32(24):2992\u20133000.","journal-title":"Oncogene"},{"issue":"11","key":"1486_CR9","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/nm.3363","volume":"19","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa K, et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med. 2013;19(11):1496\u2013504.","journal-title":"Nat Med"},{"issue":"5","key":"1486_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/epi.13348","volume":"57","author":"D Wang","year":"2016","unstructured":"Wang D, et al. Targeting of microRNA-199a-5p protects against pilocarpine-induced status epilepticus and seizure damage via SIRT1-p53 cascade. Epilepsia. 2016;57(5):706\u201316.","journal-title":"Epilepsia"},{"key":"1486_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.metabol.2017.05.003","volume":"73","author":"P Zhang","year":"2017","unstructured":"Zhang P, et al. Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway. Metabolism. 2017;73:9\u201321.","journal-title":"Metabolism"},{"issue":"1","key":"1486_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3892\/ijmm.2016.2806","volume":"39","author":"H Lu","year":"2017","unstructured":"Lu H, Wang B. SIRT1 exerts neuroprotective effects by attenuating cerebral ischemia\/reperfusion-induced injury via targeting p53\/microRNA-22. Int J Mol Med. 2017;39(1):208\u201316.","journal-title":"Int J Mol Med"},{"issue":"4","key":"1486_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrm1616","volume":"6","author":"L Bordone","year":"2005","unstructured":"Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol. 2005;6(4):298\u2013305.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1486_CR14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fendo.2014.00166","volume":"5","author":"R Yacoub","year":"2014","unstructured":"Yacoub R, Lee K, He JC. The role of SIRT1 in diabetic kidney disease. Front Endocrinol (Lausanne). 2014;5:166.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1486_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12272-013-0019-4","volume":"36","author":"S Kume","year":"2013","unstructured":"Kume S, et al. Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy. Arch Pharm Res. 2013;36(2):230\u20136.","journal-title":"Arch Pharm Res"},{"issue":"4","key":"1486_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.prp.2016.02.001","volume":"212","author":"L Ma","year":"2016","unstructured":"Ma L, et al. Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat. Pathol Res Pract. 2016;212(4):310\u20138.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"1486_CR17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1681\/ASN.2010070705","volume":"22","author":"T Kimura","year":"2011","unstructured":"Kimura T, et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol. 2011;22(5):902\u201313.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1486_CR18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4161\/auto.19419","volume":"8","author":"S Liu","year":"2012","unstructured":"Liu S, et al. Autophagy plays a critical role in kidney tubule maintenance, aging and ischemia-reperfusion injury. Autophagy. 2012;8(5):826\u201337.","journal-title":"Autophagy"},{"issue":"2","key":"1486_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","volume":"107","author":"J Luo","year":"2001","unstructured":"Luo J, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001;107(2):137\u201348.","journal-title":"Cell"},{"key":"1486_CR20","doi-asserted-by":"publisher","first-page":"908185","DOI":"10.1155\/2011\/908185","volume":"2011","author":"M Kitada","year":"2011","unstructured":"Kitada M, et al. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa\/fa) rats: a model of type 2 diabetes. Exp Diabetes Res. 2011;2011:908185.","journal-title":"Exp Diabetes Res"},{"issue":"1","key":"1486_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ki.2014.226","volume":"87","author":"J Peng","year":"2015","unstructured":"Peng J, et al. Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injury. Kidney Int. 2015;87(1):137\u201350.","journal-title":"Kidney Int"},{"issue":"5682","key":"1486_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1126\/science.1099196","volume":"305","author":"HY Cohen","year":"2004","unstructured":"Cohen HY, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305(5682):390\u20132.","journal-title":"Science"},{"issue":"9","key":"1486_CR23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0962-8924(02)02342-5","volume":"12","author":"J Smith","year":"2002","unstructured":"Smith J. Human Sir2 and the \u2018silencing\u2019 of p53 activity. Trends Cell Biol. 2002;12(9):404\u20136.","journal-title":"Trends Cell Biol"},{"key":"1486_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2016.12.022","volume":"11","author":"L Xiao","year":"2017","unstructured":"Xiao L, et al. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2\/PINK1. Redox Biol. 2017;11:297\u2013311.","journal-title":"Redox Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1486-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1486-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1486-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T19:07:27Z","timestamp":1559156847000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1486-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1486"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1486-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"146"}}